Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Non Operating Income: 2024-2025

Historic Non Operating Income for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $5.9 million.

  • Kura Oncology's Non Operating Income rose 7.32% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year change of. This contributed to the annual value of $21.2 million for FY2024, which is 61.16% up from last year.
  • As of Q3 2025, Kura Oncology's Non Operating Income stood at $5.9 million, which was down 10.13% from $6.5 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Non Operating Income ranged from a high of $7.5 million in Q1 2025 and a low of $4.9 million during Q1 2024.
  • Moreover, its 2-year median value for Non Operating Income was $5.6 million (2024), whereas its average is $5.9 million.
  • Data for Kura Oncology's Non Operating Income shows a peak YoY surged of 52.16% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Non Operating Income (Quarterly) stood at $5.3 million in 2024, then grew by 7.32% to $5.9 million in 2025.
  • Its Non Operating Income stands at $5.9 million for Q3 2025, versus $6.5 million for Q2 2025 and $7.5 million for Q1 2025.